Divi's Laboratories Ltd
NSE:DIVISLAB

Watchlist Manager
Divi's Laboratories Ltd Logo
Divi's Laboratories Ltd
NSE:DIVISLAB
Watchlist
Price: 5 998.35 INR 0.36% Market Closed
Market Cap: 1.6T INR
Have any thoughts about
Divi's Laboratories Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Divi's Laboratories Ltd

Current Assets 96.8B
Cash & Short-Term Investments 3.5B
Receivables 24B
Other Current Assets 69.3B
Non-Current Assets 58B
Long-Term Investments 820m
PP&E 55.1B
Intangibles 40m
Other Non-Current Assets 2B
Current Liabilities 12.8B
Accounts Payable 8.2B
Accrued Liabilities 2.2B
Other Current Liabilities 2.3B
Non-Current Liabilities 6.2B
Long-Term Debt 20m
Other Non-Current Liabilities 6.2B

Balance Sheet
Divi's Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
176
179
208
252
130
431
20 303
12 148
1 697
3 630
Cash
0
0
208
252
130
231
218
219
289
230
Cash Equivalents
176
179
0
0
0
200
20 085
11 929
1 408
3 400
Short-Term Investments
7 839
8 553
16 881
19 758
14 996
9 714
0
0
0
0
Total Receivables
7 761
9 109
9 393
11 333
12 965
16 812
11 696
12 730
20 372
23 950
Accounts Receivables
7 416
8 809
9 009
10 144
11 634
14 134
16 765
24 239
17 925
21 560
Other Receivables
345
300
384
1 189
1 331
2 678
5 069
11 509
2 446
2 390
Inventory
11 798
12 206
13 561
13 939
18 308
18 877
21 764
29 159
30 343
32 640
Other Current Assets
160
223
64
70
102
965
7 984
29 478
40 706
36 530
Total Current Assets
27 735
30 270
40 105
45 351
46 501
46 798
61 747
83 515
93 117
96 750
PP&E Net
15 231
16 998
19 995
21 094
25 756
36 979
44 095
47 875
49 292
55 130
PP&E Gross
0
16 998
19 995
21 094
25 756
36 979
44 095
47 875
49 292
55 130
Accumulated Depreciation
0
7 551
2 312
3 712
5 375
7 209
9 735
12 815
16 208
19 960
Intangible Assets
40
29
33
66
41
36
50
75
53
40
Note Receivable
424
1 546
1 137
1 308
2 586
1 494
1 106
1 102
198
1 280
Long-Term Investments
0
0
0
0
5 473
0
0
720
771
820
Other Long-Term Assets
400
178
316
40
26
50
743
461
957
680
Total Assets
43 829
N/A
49 021
+12%
61 585
+26%
67 859
+10%
80 383
+18%
85 357
+6%
107 741
+26%
133 747
+24%
144 388
+8%
154 700
+7%
Liabilities
Accounts Payable
2 269
2 327
4 458
4 112
4 923
5 907
7 632
7 957
7 625
8 240
Accrued Liabilities
807
1 077
1 111
1 068
1 700
1 782
2 381
3 074
2 380
2 230
Short-Term Debt
251
414
357
631
1 056
336
4
0
0
0
Current Portion of Long-Term Debt
5
6
0
0
0
8
8
8
5
10
Other Current Liabilities
1 229
1 371
668
724
789
1 235
1 100
917
1 001
2 300
Total Current Liabilities
4 560
5 195
6 595
6 534
8 468
9 268
11 125
11 956
11 011
12 780
Long-Term Debt
11
5
0
0
0
45
37
29
28
20
Deferred Income Tax
965
773
1 264
1 927
2 212
2 740
3 381
4 214
5 372
5 820
Other Liabilities
70
116
153
150
132
205
253
267
306
370
Total Liabilities
5 606
N/A
6 088
+9%
8 011
+32%
8 611
+7%
10 811
+26%
12 258
+13%
14 795
+21%
16 465
+11%
16 717
+2%
18 990
+14%
Equity
Common Stock
265
531
531
531
531
531
531
531
531
530
Retained Earnings
36 894
41 603
52 244
57 918
68 242
71 636
91 480
115 797
126 090
134 120
Additional Paid In Capital
1 064
799
799
799
799
799
799
799
799
800
Other Equity
0
0
0
0
0
134
136
155
251
260
Total Equity
38 223
N/A
42 933
+12%
53 574
+25%
59 248
+11%
69 572
+17%
73 099
+5%
92 946
+27%
117 282
+26%
127 671
+9%
135 710
+6%
Total Liabilities & Equity
43 829
N/A
49 021
+12%
61 585
+26%
67 859
+10%
80 383
+18%
85 357
+6%
107 741
+26%
133 747
+24%
144 388
+8%
154 700
+7%
Shares Outstanding
Common Shares Outstanding
265
265
265
265
265
265
265
265
265
265

See Also

Discover More